These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.
    Author: Houston JG, Banks MN, Binnie A, Brenner S, O'Connell J, Petrillo EW.
    Journal: Drug Discov Today; 2008 Jan; 13(1-2):44-51. PubMed ID: 18190863.
    Abstract:
    We review strategic approaches taken over an eight-year period at BMS to implement new high-throughput approaches to lead discovery. Investments in compound management infrastructure and chemistry library production capability allowed significant growth in the size, diversity and quality of the BMS compound collection. Screening platforms were upgraded with robust automated technology to support miniaturized assay formats, while workflows and information handling technologies were streamlined for improved performance. These technology changes drove the need for a supporting organization in which critical engineering, informatics and scientific skills were more strongly represented. Taken together, these investments led to significant improvements in speed and productivity as well a greater impact of screening campaigns on the initiation of new drug discovery programs.
    [Abstract] [Full Text] [Related] [New Search]